Clinical Trial Update: Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine with or without bavituximab in previously untreated stage IV pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bavituximab (bavituximab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED